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Antiviral RNAiOriginating from Africa, Usutu virus (USUV) ﬁrst emerged in Europe in 2001. This mosquito-borne ﬂavivirus
caused high mortality rates in its bird reservoirs, which strongly resembled the introduction of West Nile virus
(WNV) in 1999 in the United States. Mosquitoes infected with USUV incidentally transmit the virus to other ver-
tebrates, including humans, which can result in neuroinvasive disease. USUV and WNV co-circulate in parts of
southern Europe, but the distribution of USUV extends into central and northwestern Europe. In the ﬁeld, both
viruses have been detected in the northern house mosquito Culex pipiens, of which the potential for USUV
transmission is unknown. To understand the transmission dynamics and assess the potential spread of USUV,
we determined the vector competence of C. pipiens for USUV and compared it with the well characterized
WNV. We show for the ﬁrst time that northwestern European mosquitoes are highly effective vectors for
USUV, with infection rates of 11% at 18 °C and 53% at 23 °C, which are comparable with values obtained for
WNV. Interestingly, at a high temperature of 28 °C, mosquitoes became more effectively infected with USUV
(90%) than with WNV (58%), which could be attributed to barriers in the mosquito midgut. Small RNA deep
sequencing of infected mosquitoes showed for both viruses a strong bias for 21-nucleotide small interfering
(si)RNAs, which map across the entire viral genome both on the sense and antisense strand. No evidence for
viral PIWI-associated RNA (piRNA) was found, suggesting that the siRNA pathway is the major small RNA path-
way that targets USUV and WNV infection in C. pipiensmosquitoes.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
In the last two decades a number of clinically signiﬁcant arthropod-
borne viruses (arboviruses) have emerged and re-emerged in continen-
tal Europe. Autochthonous transmission of dengue virus has occurred in
France in 2014 [1] and chikungunya virus transmission has been record-
ed in Italy (2007) [2] and France (2010, 2014) [3,4]. Both of these
viruses are transmitted by the invasive Asian tiger mosquito Aedes
albopictus, which has colonized parts of Europe [5]. Native Culex
mosquitoes are themain vectors for two pathogenic lineages of another
arbovirus, West Nile virus (WNV), which are now endemic in southern
Europe [6]. Mosquitoes and birds maintain the enzootic transmission
cycle of WNV. Infected mosquitoes, however, may also feed on other.
. This is an open access article undervertebrates resulting in frequent infections in humans and horses [7].
In 1999, WNV was introduced in the United States. The outbreak that
followed was characterized by high mortality rates in various
American bird species and resulted in the largest outbreak of human
neuroinvasive disease to date [8].
In Austria (2001), a sudden and substantial die-off occurred in Eur-
asian blackbirds (Turdus merula), closely resembling the 1999 WNV
outbreak in the United States. Not WNV, but a related ﬂavivirus (family
Flaviviridae), Usutu virus (USUV), was identiﬁed in infected birds. This
was the ﬁrst isolation of USUV on the European continent [9]. The
virus was ﬁrst discovered in South Africa in 1959 and since then it has
been identiﬁed in a number of African countries [10]. After the initial
outbreak in Austria, USUV activity has been detected in birds from
Spain, Italy, Switzerland, the Czech Republic, Hungary, United
Kingdom, Poland, Croatia, Germany and Belgium [11,12]. In some
southern European countries USUV co-circulates with WNV [13]. Thethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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USUV to be monitored via the surveillance of dead birds [14]. Most of
the USUV-positive bird species were blackbirds (T. merula), which
belong to the same genus as the suspected WNV reservoir in the
United States, the American robin (Turdus migratorius) [15]. USUV
infected mosquitoes may also feed on other vertebrates, and the virus
has been detected in horses [16] and bats [17]. Infections in humans
have resulted in two diagnosed clinical cases in Africa [10]. In Europe,
two Italian and three Croatian patients with neuroinvasive disease
have been reported [18–20], attributed to USUV. However, serological
evidence suggests that less severe and subclinical cases of human
USUV infections occur regularly in endemic areas [21–23].
Similar toWNV, USUV is mostly transmitted by Culexmosquitoes. In
Africa USUV has been isolated from Culex neavei, Culex perfuscus, Culex
univitattus and Culex quinquefasciatus. Additionally, USUV has also
been detected in a number of mosquito species from other genera
[10]. Among European mosquito species, USUV is mostly found in the
northern house mosquito (Culex pipiens), which is abundant through-
out the northern hemisphere [13].
The presence of competentmosquitoes dictates the potential spread
of arthropod-borne pathogens. Vectors are considered competentwhen
they can transmit the pathogen from one vertebrate host to the next.
Arboviruses, like USUV, are ingested by the mosquito via a blood meal
of an infected vertebrate host, infect the epithelial cells that line the
mosquito midgut, escape to the hemolymph, and ﬁnally accumulate in
the saliva to be transmitted during the next blood meal [24]. Determin-
ing vector competence provides an insight into the viral transmission
dynamics and is essential to assess the risk for future outbreaks. The
only laboratory experiments with USUV were done with the African
mosquito, C. neavei [25]. To better understand, predict, and assess the
potential spread of USUV in Europe we investigated the vector compe-
tence of the northern house mosquito C. pipiens for USUV. In addition,
we investigated the activity of RNA interference (RNAi), which is a
major antiviral defense system of mosquitoes and other insects [34,
35]. The RNAi response against USUV has never been studied.
Here we show for the ﬁrst time that C. pipiens is a highly effective
European USUV vector. We provide an insight into the virus replication
dynamics and the antiviral RNAi response within the mosquito vector
and show how the vector competence of USUV relates to that of WNV
at different temperatures.
Materials and methods
Cells and viruses
C6/36 cells were grown in Leibovitz L15 (Life Technologies,
The Netherlands) medium, which was supplemented with 10%
FBS. Vero E6 cells were cultured with DMEM Hepes (Life Technologies,
The Netherlands)-buffered medium supplemented with 10% FBS
containing penicillin (100 IU/ml) and streptomycin (100 μg/ml).
When Vero E6 cells were infected with mosquito lysates or saliva the
growth medium was supplemented with fungizone (2.5 μg/ml) and
gentamycin (50 μg/ml). This medium will be referred to as fully
supplemented medium. Passage 2 (P2) virus stocks of USUV, Bologna
'09 (GenBank accession no. HM569263) [26] and WNV Gr'10 lineage 2
(GenBank accession no. HQ537483.1) [27,28] were grown on C6/36
cells and titrated on Vero E6 cells.
Mosquito rearing
The European C. pipiens colony originated from Brummen, The
Netherlands (°05′23.2″N 6°09′20.1″E) and was established in 2010
and maintained at 23 °C. The mosquito colony was kept in Bugdorm
cages with a 16:8 light:dark (L:D) cycle and 60% relative humidity
(RH), and provided with a 6% glucose solution as a food source. Bovine
or chicken whole blood was provided through the Hemotek PS5(Discovery Workshops, UK) for egg production. Egg rafts were allowed
to hatch in tap water supplemented with Liquifry No. 1 (Interpet Ltd.,
UK). Larvae were fed with a 1:1:1 mixture of bovine liver powder,
ground rabbit food and ground koi food.
In vivo infections
Two-to-ﬁve day oldmosquitoeswere infected either via ingestion of
an infectious blood meal or via intrathoracic injections. Oral infections
were performed by mixing whole chicken blood with the respective
P2 virus stock to the indicated ﬁnal concentration. Mosquitoes were
allowed tomembrane feed, using theHemotek system, in a dark climate
controlled room (24 °C, 70% RH) [29]. After 1 h,mosquitoes were sedat-
ed with 100% CO2 and the fully engorged females were selected. During
intrathoracic injections the mosquitoes were sedated with CO2 by plac-
ing them on a semi-permeable pad, attached to 100% CO2. Mosquitoes
were infected by intrathoracic injection using the Drummond nanoject
2 (Drummond Scientiﬁc Company, United States). Virus-exposed mos-
quitoes were incubated at the indicated temperatures with a 16:8 L:D
cycle and fed with 6% sugar water during the course of the experiment.
Salivation assay
Transmission was determined using the forced salivation technique
[29]. Brieﬂy,mosquitoeswere sedatedwith 100% CO2 and their legs and
wingswere removed. Their proboscis was inserted into a 200 μl ﬁlter tip
containing 5 μl of salivationmedium (50% FBS and 50% sugarwater)W/
V 50%). Mosquitoes were allowed to salivate for 45 min. Mosquito bod-
ies were frozen in individual Eppendorf tubes containing 0.5 mm zirco-
nium beads at−80 °C. The mixture containing the saliva was added to
55 μl of fully supplemented growth medium.
Infectivity assays
Frozen mosquito bodies were homogenized in the bullet blender
storm (Next Advance, United States) in 100 μl of fully supplemented
medium and centrifuged for 90 s at 14,500 rpm in an Eppendorf
Minispin Plus centrifuge (14,000 cf) inside the biosafety cabinet of the
Wageningen biosafety level 3 laboratory. Thirty μl of the supernatant
from the mosquito homogenate or the saliva-containing mixture was
inoculated on a monolayer of Vero cells in a 96-well plate. After 2–4 h
incubation the medium was replaced by 100 μl of fresh fully supple-
mented medium.Wells were scored for virus speciﬁc cytopathic effects
(CPE) at three days post infection. Viral titers were determined using
10 μl of the supernatant from the mosquito homogenate in an end
point dilution assay on Vero E6 cells. Infections were scored by CPE,
three days post infection.
Analysis of small RNA libraries
Pools of twelve WNV or USUV infected mosquitoes were lysed in
TRIzol (Life Technologies) reagent and total RNA was isolated. The isola-
tion and sequencing of small RNAs were described previously [30]. In
short, RNA was size separated by PAGE gel electrophoresis and small
RNAs (19–33 nucleotides) were isolated. The small RNA library was pre-
pared with the TruSeq Small RNA Sample Preparation Kit (Illumina) and
sequenced on an Illumina HiSeq 2500 by Baseclear (www.baseclear.nl).
FASTQ sequence reads were generated with the Illumina Casava pipeline
(version 1.8.3) and initial quality assessmentwas performed by Baseclear
using in-house scripts and the FASTQC quality control tool (version
0.10.0). FASTQ sequence reads that passed this quality control were ana-
lyzedwith Galaxy [31]. Sequence readswere clipped from the adapter se-
quence (TruSeq 3′ adapter indexes #1 and #5) and mapped with Bowtie
(version 1.1.2) [28] to the WNV (GenBank: HQ537483.1) and USUV
(GenBank: HM569263.1) genomes. Size proﬁles of the viral small RNAs
were obtained from all reads that mapped to their respective genomes
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small RNAs shows the number of 5′ ends at each nucleotide position of
the viral genome. Read counts for the size proﬁles and genome distribu-
tionswere normalized against the total library and are presented as a per-
centage of the library. Probing piRNAs for an overlap bias was performed
using the Mississippi Galaxy Instance available from https://mississippi.
snv.jussieu.fr/. The small RNA libraries were mapped to the WNV or
USUV genomes using Bowtie2 and 25–30 nt readswere selected to calcu-
late the overlap probability as described [32]. The nucleotide bias of the
25–30 nt viral small RNAs was determined using the Weblogo 3.3 tool
available at the Galaxy main server.
Results
C. pipiens is a highly competent vector for USUV
Recently we showed that C. pipiens from north-western Europe is a
highly competent vector for pathogenic WNV isolates [29]. To evaluate
vector competence of this mosquito for USUV, mosquitoes were offered
a blood meal containing a 50% tissue culture infectious dose (TCID50) of
4 ∗ 107 USUV or WNV per ml. The fully engorged females were main-
tained at 28 °C. Virus in the saliva of a mosquito is a prerequisite for
transmission and therefore used as a proxy for transmission. We thus
isolated saliva from individual mosquitoes at 14 dpi and detected infec-
tious USUV or WNV particles by end-point dilution assays. The blood
meal that contained WNV infected 46% of the mosquitoes, whereas
the blood meal that contained USUV infected a signiﬁcantly larger
percentage (80%) of mosquitoes (Fig. 1A, Fisher's exact test, P b 0.05).
From the mosquitoes that ingested a WNV-containing blood meal,
33% had infectious WNV in their saliva, whereas a USUV containing
blood meal resulted in 69% of mosquitoes with infectious saliva
(Fig. 1A, Fisher's exact test P b 0.05).
To circumvent the midgut infection barrier [33], C. pipiens mosqui-
toes were inoculated intrathoracically with 5.5 ∗ 103 TCID50 of either
virus, resulting in infection and transmission rates of both WNV and
USUV up to 100% (Fig. 1B). Taken together, USUV not only infects a
large percentage of C. pipiens mosquitoes but also effectively dissemi-
nates into their saliva. This indicates that these WNV-competent
mosquitoes are even more effective as vector for USUV than WNV. In
addition, the differential infectivity and transmissibility of both viruses
after an infectious blood meal but not after intrathoracic injection sug-
gests that the midgut epithelial cells play a differentiating role that
determines vector competence.
USUV replication in the mosquito vector
To investigate whether or not the increased dissemination of USUV
relates to higher viral titers in the vector, the viral titers present inFig. 1. Culex pipiens is a highly competent vector for USUV. Mosquitoes were offered an infec
infection mosquito saliva was collected and the mosquito body was homogenized in a cell cu
detect the presence of either WNV or USUV in the mosquito bodies and saliva. Bars represen
exact test, P b 0.05).individual mosquito bodies were determined using end point dilution
assays. Interestingly, mosquitoes that were orally infected with either
WNV or USUV showed a similar variation in viral titers (Fig. 2, mean
TCID50 of 1.1 ∗ 106 and 1.5 ∗ 106 per ml, respectively). In contrast, intra-
thoracic injection of eitherWNVor USUV resulted in signiﬁcantly differ-
ent viral titers, with a mean TCID50 of 8.1 ∗ 106 and 2.7 ∗ 105 per ml,
respectively (Fig. 2, Student t-test, P b 0.05). In addition, USUVdisplayed
viral titers that were 30 times lower compared with WNV, but without
compromising dissemination to the salivary glands. This suggests that
the bottleneck for vector competence is presented by the midgut epi-
thelium, which differentially affects viral replication ofWNV and USUV.
WNV and USUV produce viral siRNAs in infected C. pipiens
RNAi is activated by the recognition and cleavage of viral dsRNA into
21-nt small-interfering RNAs (siRNA) by the Dicer2 (DCR2) exo-
ribonuclease [34,35]. To investigate whether or not the RNAi pathway
is activated by WNV and USUV infections in C. pipiens, small RNAs
were isolated from pools of WNV or USUV infected mosquitoes and
analyzed using deep-sequencing. For both viruses, viral small RNA pop-
ulations are strongly biased for 21 nucleotide siRNAs (Fig. 3A), which
map across the entire viral genome both on the viral sense and
antisense strand (Fig. 3B). Recent reports have shown that a second
class of small RNAs, known as viral PIWI-interacting RNAs (vpiRNAs),
are produced in Aedes mosquitoes and mosquito cells in response to
arbovirus infections. These small RNAs are 25–30 nt in size and, due to
a speciﬁc ampliﬁcation mechanism, known as the ping–pong loop,
they can be distinguished by a characteristic sequence signature
[36–40]. The RNAi response against USUV infection has never been
studied. Probing the 25–30 nucleotides viral small RNAs for this signa-
ture, we were unable to identify vpiRNAs derived from either WNV or
USUV (Supplemental Fig. S1) in Culexmosquitoes. Thus, the siRNApath-
way is themajor small RNA pathway that targets these two viruses in C.
pipiensmosquitoes upon infection.
USUV infection is more effective at higher ambient temperatures
C. pipiensmosquitoes are more competent for WNV at higher ambi-
ent temperatures [29].While both USUV andWNV are endemic in parts
ofMediterranean Europe, USUValso extends its distribution into central
and northwestern parts of Europe. We hypothesized that the ambient
temperature could differentially affect the vector competence to either
virus.
Oral infections were performed by offering the mosquitoes a blood
meal containing either USUV or WNV, with 3.2 ∗ 107 and 2.2 ∗ 108
TCID50 per ml, respectively. We chose to use higher WNV titers to com-
pensate for the lower vector competence for WNV (Fig. 1). Fully
engorged females were incubated at three different temperaturestious blood meal (A) or were injected (B) with either WNV or USUV. Fourteen days post
lture medium. The mosquito homogenate and saliva were incubated on Vero E6 cells to
t the percentage of positive samples. Asterisk indicates a signiﬁcant difference (Fisher's
Fig. 2. USUV and WNV replicate to equally high titers in Culex pipiens after an infectious
blood meal but not after injection of the viruses. Homogenates from infected mosquitoes
were used in end point dilution assays and the tissue culture infectious dose 50%
(TCID50)/ml was determined. Data points represent individual mosquitoes infected with
either USUV or WNV via the indicated route. Lines show the mean and whiskers the
standard error of the mean. Asterisk indicates a signiﬁcant difference (t-test, P b 0.05).
Fig. 4. r. After infectious blood meals, engorged mosquitoes were incubated at three
different temperatures for fourteen days, before determining the presence of WNV and
USUV. Data points indicate the percentage of infected mosquitoes from the total
sample size (n N 25). Asterisks indicate signiﬁcant differences between the temperatures
(*P b 0.001, Fisher's exact test, for both WNV and USUV) and between WNV and USUV
at 28 °C (**P b 0.01, Fisher's exact test).
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summer (July–August) temperature in northwestern Europe, an inter-
mediate temperature, and the mean diurnal summer temperature for
Mediterranean Europe, respectively [41]. After two weeks the mosqui-
toes were homogenized and the respective viruses were detected.
WNV displayed higher infection rates at higher temperatures, infecting
17% at 18 °C, 43% at 23 °C and 58% at 28 °C (Fig. 4, open symbols). At
lower temperatures USUV infected a similar percentage of mosquitoes
(11% at 18 °C and 53% at 23 °C). Interestingly, at 28 °C, 90% of the mos-
quitoes were infected with USUV (Fig. 4, closed symbols), which was
signiﬁcantly more as compared with the 58% for WNV (Fisher's
exact test, P b 0.01). This was especially signiﬁcant as the titer used
for USUV in the infectious blood meals was seven times lower. This
indicates that USUV is highly infectious for European C. pipiensFig. 3. RNAi activity inWNV and USUV infected mosquitoes. (A) Size proﬁle of the small RNAs
positive viral RNA strand (black) are shown above and reads mapping to the negative strand (g
(left panel) or USUV (right panel) genomes. Reads that map the positive strands are depicted in
reads in A and B was normalized against the total size of the library and is displayed as the permosquitoes and that temperature differentially affects the susceptibility
of mosquitoes to either USUV or WNV.
Discussion
Here we show for the ﬁrst time that USUV not only infects C. pipiens,
but also effectively disseminates and accumulates in its saliva. In the
ﬁeld USUV is mostly detected in Culex species mosquitoes, although it
has also been found in mosquitoes from four other genera within the
family of Culicidae. To what extent mosquitoes from these genera may
contribute to the dispersal of USUV is unclear. In southern Europe,
USUV was detected in C. pipiens, which is the most abundant mosquito
species in Europe and a competent WNV vector [10,13,29]. Northern
Europe has a second abundant Culex species: Culex torrentium. Itmapping to the genome of WNV (left panel) or USUV (right panel). Reads mapping to the
ray) below the x-axes. (B) Genome distribution of 21 nucleotides vsiRNAs across theWNV
red, reads that map to the negative strands are depicted in blue. The number of small RNA
centage of the library.
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act as a transmission vector for USUV and if, to what extent.
In addition to competent USUV vectors, sufﬁcient vertebrate species
are required as amplifying hosts. Susceptible bird species are prevalent
in Europe as USUVhas been detected in a large number of avian species,
most notably within the Turdus genus [9,14]. In addition to birds, other
vertebrates can become infected with USUV. Like WNV, humans and
horses are incidental hosts. Whether bats develop viral titers that are
high enough to contribute to the dispersal of USUV is unknown, but if
this is a reservoir it could dramatically inﬂuence transmission model
predictions [17]. Experimental WNV infections in birds can result in
viremia above 109 plaque forming units perml, which is sufﬁcient to in-
fect blood feeding mosquitoes [27,42]. In the experiments presented
here, the chicken blood used for infectious blood meals contained
USUV titers of maximally 4 ∗ 107 TCID50 per ml. Higher titers in the
blood of USUV infected birds may further increase the percentage of
vectors able to transmit USUV after blood feeding.
Both USUV and WNV disseminated into the saliva of up to 100% of
mosquitoes that were intrathoracically injected with either virus
(Fig. 1B). Interestingly, the viral titers that are present in orally infected
mosquitoeswere variable,whereas infection by injection displayed only
a limited variation (Fig. 2). This suggests that the midgut acts as the
major bottleneck for dissemination of the virus. Potentially, the induc-
tion of antiviral responses, and/or selective pressure for certain viral
quasi speciesmay inﬂuence subsequent viral replication and dissemina-
tion. Injection ofWNValso resulted in titers thatwere higher than those
of blood fed or USUV-injected mosquitoes. Together with the lower
vector competence, this suggests that the barriers in the midgut
epithelial cells of C. pipiens aremore effective againstWNVas compared
with USUV.
Small RNA pathways are key to antiviral immunity in insects, includ-
ing mosquitoes. In response to WNV infections, virus-derived siRNAs
(vsiRNA) have been detected in C. quinquefasciatus [43]. We show that
both WNV and USUV elicit a strong RNAi response by displaying the
DCR2 dependent vsiRNAs of 21 nucleotides, which map to both the ge-
nomic positive RNA strand and the complementary negative strand.
We did not identify vpiRNAs derived from WNV or USUV. These viral
small RNAs have until nowonly been identiﬁed in Aedesmosquitoes, pri-
marily for viruses of the Togaviridae and Bunyaviridae families [36,37,39,
40]. Yet, vpiRNA production fromboth dengue virus and cell fusing agent
virus (both Flaviviridae) has been suggested to occur in RNAi-deﬁcient
cells [44]. The lack of vpiRNAs in the infection models presented here
could therefore be attributed to an inability of Culex mosquitoes to
process viral RNA into vpiRNAs or to ﬂaviviral RNA being an inferior sub-
strate for vpiRNA production. Thus, our data suggest that siRNA-
mediated RNA interference is the major small RNA pathway targeting
WNVandUSUV in C. pipiensmosquitoes. Yet, therewere no apparent dif-
ferences in vsiRNA levels that could explain the differential transmission
rates between the two viruses.
Despite the observed differences in infectivity and transmissibility,
both WNV and USUV can effectively be transmitted by C. pipiens. How-
ever, their distribution throughout Europe only has a limited overlap.
The dispersal of WNV has a strong correlation with mean summer tem-
peratures,which can be explained by the vector competence forWNVat
the corresponding temperatures [29]. USUV activity is also found in
more temperate regions, but surprisingly the infectivity in C. pipiens
showed a strong temperature dependency, which was more pro-
nounced than for WNV. In the experiments presented here, we used a
constant incubation temperature that represented a mean summer
temperature. However, diurnal temperature ﬂuctuations around this
mean may have additional effects on the vector competence. Indeed,
the vector competence of Ae. aegypti for dengue virus is inﬂuenced by
the diurnal temperature range. Fluctuations around lower mean tem-
peratures (b18 °C) increased the vector competence in comparison
with mosquitoes that were incubated at identical, yet constant, mean
temperatures [45]. Because C. pipiens is more competent for USUV athigher temperatures, temperature ﬂuctuations above a relatively low
mean may still enable USUV to have a higher vectorial capacity
compared with WNV, but this needs further experimental evidence.
Other factors involved in transmission are e.g., population density of
vectors and amplifying hosts (birds), mosquito survival and host
feeding behavior of C. pipiens.
In conclusion, both USUV andWNV can be transmitted by European
C. pipiens mosquitoes, with increased oral infection rates at higher
temperatures. At higher temperatures, however, C. pipiens is signiﬁcant-
ly more competent for USUV than for WNV.
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.onehlt.2015.08.002.
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